AAPG

Profile

Full Name

Ascentage Pharma Group International

Ticker Symbol

AAPG

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

China

IPO

January 24, 2025

Indexes

Not included

Website

http://www.ascentage.cn

Employees

567

Key Details

Price

$26.30(+3.12%)

Market cap

$2.29B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$136.67M(+335.50% YoY)

Annual EPS

-$0.75(+59.73% YoY)

PE ratio

-

Next earnings date

Aug 22, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$26.30
AAPG price is $26.30

30-Day Relative Volume

0.88
AAPG 30-day relative volume is 0.88

Price Performance

Price Most recent change

+3.12%
AAPG price was up +3.12% on Apr 25, 2025

Price YTD change

-
AAPG price ytd change is unknown

Price 1-year change

-
AAPG price 1-year change is unknown

Price 3-year change

-
AAPG price 3-year change is unknown

Price Range

Price All-time high

$26.50
AAPG price is currently -0.77% below its historical high of $26.50

Price 3-year low

$16.50
AAPG price is currently +59.36% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$2.29B
AAPG market capitalization is $2.29 billion

Market cap 3-year change

-
AAPG market capitalization 3-year change is unknown

Market cap All-time high

$2.29B
AAPG market capitalization is currently at an all-time high

Market cap sector rank

-
AAPG market capitalization is unknown

Shares Outstanding

Shares Outstanding 1-Year Change

+20.01%
AAPG shares outstanding is up +20.01% year-on-year

Shares Outstanding 3-Year Change

+32.48%
AAPG shares outstanding is up +32.48% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.60
AAPG beta is 0.60

200-day SMA

$19.56
AAPG price is currently +34.41% above its 200-day simple moving average

50-day SMA

$20.00
AAPG price is currently +31.47% above its 50-day simple moving average

RSI

71.22
AAPG 14-day relative strength index is 71.22

Volume

0.88
AAPG 30-day relative volume is 0.88

ATR

$1.50
AAPG average true range is $1.50

10-day Historical Volatility

95.19%
AAPG 10-day historical volatility is 95.19%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$136.67M
AAPG annual revenue is $136.67 million

Revenue Analysts estimate

$532.98M
AAPG annual revenue is currently -74.36% lower than the consensus analysts' forecast

Revenue 1-year change

+335.5%
AAPG annual revenue is up +335.5% year-on-year

Revenue Sector rank

-
AAPG annual revenue is unknown

EPS

EPS

-$0.75
AAPG annual earnings per share is -$0.75

EPS Analysts estimate

-$2.40
AAPG annual earnings per share is currently -68.93% lower than the consensus analysts' forecast

EPS 1-year change

+59.73%
AAPG annual earnings per share is up +59.73% year-on-year

EPS Sector rank

-
AAPG annual earnings per share is unknown

Profit

Gross profit

$132.61M
AAPG annual gross profit is $132.61 million

Gross margin

97.03%
AAPG annual gross profit margin is 97.03%

Operating profit

-$51.53M
AAPG annual operating income is -$51.53 million

Operating margin

-37.70%
AAPG annual operating profit margin is -37.70%

Net income

-$56.50M
AAPG annual net profit is -$56.50 million

Net margin

-41.34%
AAPG annual net profit margin is -41.34%

Expenses

Total expenses

$188.20M
AAPG annual total expenses is $188.20 million

Operating expenses

$184.14M
AAPG annual total operating expenses is $184.14 million

Cost of goods sold

$4.05M
AAPG annual cost of goods sold is $4.05 million

Selling, general & administrative expenses

$53.39M
AAPG annual SGA is $53.39 million

Depreciation and amortization

$12.98M
AAPG annual depreciation & amortization is $12.98 million

Interest expense

$8.98M
AAPG annual interest expense is $8.98 million

Income tax

$1.45M
AAPG annual income tax is $1.45 million

EBIT & EBITDA

EBIT

-$46.10M
AAPG annual earnings before interest & taxes is -$46.10 million

EBITDA

-$46.10M
AAPG annual EBITDA is -$46.10 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$358.60M
AAPG annual total assets is $358.60 million

Non current assets

$156.66M
AAPG annual long term assets is $156.66 million

Current assets

$201.94M
AAPG annual total current assets is $201.94 million

Cash and cash equivalents

$172.77M
AAPG annual cash & cash equivalents is $172.77 million

Accounts receivable

$11.39M
AAPG annual accounts receivable is $11.39 million

Inventory

$903.70K
AAPG annual inventory is $903.70 thousand

Liabilities

Total liabilities

$321.04M
AAPG annual total liabilities is $321.04 million

Long term liabilities

$161.24M
AAPG annual total long term liabilities is $161.24 million

Current liabilities

$159.81M
AAPG annual total current liabilities is $159.81 million

Accounts payable

$12.60M
AAPG annual accounts payable is $12.60 million

Debt

Total debt

$228.56M
AAPG annual total debt is $228.56 million

Total debt 1-year change

-9.77%
AAPG annual total debt is down -9.77% year-on-year

Long term debt

$121.84M
AAPG annual long term debt is $121.84 million

Short term debt

$106.72M
AAPG annual short term debt is $106.72 million

Equity & Capital

Shareholders equity

$36.19M
AAPG annual stockholders equity is $36.19 million

Book value

$36.19M
AAPG annual book value is $36.19 million

Retained earnings

-$790.47M
AAPG annual retained earnings is -$790.47 million

Working capital

$42.13M
AAPG annual working capital is $42.13 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$15.52M
AAPG annual cash flow from operations is -$15.52 million

Cash from operations 1-year change

+84.88%
AAPG annual cash flow from operations is up +84.88% year-on-year

Cash from investing

-$50.45M
AAPG annual cash flow from investing activities is -$50.45 million

Cash from investing 1-year change

-1728.05%
AAPG annual cash flow from investing activities is down -1728.05% year-on-year

Cash from financing

$43.87M
AAPG annual cash flow from financing activities is $43.87 million

Cash from financing 1-year change

-15.85%
AAPG annual cash flow from financing activities is down -15.85% year-on-year

CAPEX

CAPEX

$3.38M
AAPG annual capital expenditures is $3.38 million

CAPEX 1-year change

-57.88%
AAPG annual capital expenditures is down -57.88% year-on-year

Free Cash Flow

Free cash flow

-$18.90M
AAPG annual free cash flow is -$18.90 million

Free cash flow 1-year change

+82.92%
AAPG annual free cash flow is up +82.92% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

97.03%
AAPG annual gross profit margin is 97.03%

Operating margin

-37.70%
AAPG annual operating profit margin is -37.70%

Net margin

-41.34%
AAPG annual net profit margin is -41.34%

ROA & ROE

ROA

-15.89%
AAPG annual return on assets is -15.89%

ROE

-237.81%
AAPG annual return on equity is -237.81%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
AAPG price to earnings ratio value is unknown

PE ratio Sector rank

-
AAPG price to earnings ratio is unknown

PB Ratio

PB ratio

63.26
AAPG price to book ratio is 63.26

PB ratio Sector rank

-
AAPG price to book ratio is unknown

PS Ratio

PS ratio

-
AAPG price to sales ratio value is unknown

PS ratio Sector rank

-
AAPG price to sales ratio is unknown

Enterprise value

Enterprise value

$2.35B
AAPG enterprise value is $2.35 billion

Enterprise value Sector rank

-
AAPG enterprise value is unknown

EV/EBITDA

EV/EBITDA

-
AAPG EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
AAPG EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.26
AAPG annual current ratio is 1.26

Quick ratio

1.26
AAPG annual quick ratio is 1.26

Leverage

Debt to equity

6.20
AAPG annual debt to equity ratio is 6.20

Interest coverage ratio

-5.13
AAPG annual interest coverage ratio is -5.13

Risk & Stability

Piotroski F-Score

-
AAPG piotroski f-score value is unknown

Altman Z-Score

1.29
AAPG altman z-score is 1.29

Analyst ratings

Recent major analysts updates

Mar 27, 25 JP Morgan
Overweight

Institutional Ownership

Similar stocks

CERT logo
Certara (CERT)
DNLI logo
Denali Therapeutics (DNLI)
RXRX logo
Recursion Pharmaceuticals (RXRX)
AMRX logo
Amneal Pharmaceuticals (AMRX)
FOLD logo
Amicus Therapeutics (FOLD)
SEM logo
Select Medical Holdings (SEM)
IBRX logo
ImmunityBio (IBRX)
APLS logo
Apellis Pharmaceuticals (APLS)
TWST logo
Twist Bioscience (TWST)
  • What is the ticker symbol for Ascentage Pharma Group International?
  • Does Ascentage Pharma Group International pay dividends?
  • What sector is Ascentage Pharma Group International in?
  • What industry is Ascentage Pharma Group International in?
  • What country is Ascentage Pharma Group International based in?
  • When did Ascentage Pharma Group International go public?
  • Is Ascentage Pharma Group International in the S&P 500?
  • Is Ascentage Pharma Group International in the NASDAQ 100?
  • Is Ascentage Pharma Group International in the Dow Jones?
  • When was Ascentage Pharma Group International's last earnings report?
  • When does Ascentage Pharma Group International report earnings?

What is the ticker symbol for Ascentage Pharma Group International?

The ticker symbol for Ascentage Pharma Group International is NASDAQ:AAPG

Does Ascentage Pharma Group International pay dividends?

No, Ascentage Pharma Group International does not pay dividends

What sector is Ascentage Pharma Group International in?

Ascentage Pharma Group International is in the Healthcare sector

What industry is Ascentage Pharma Group International in?

Ascentage Pharma Group International is in the Biotechnology industry

What country is Ascentage Pharma Group International based in?

Ascentage Pharma Group International is headquartered in China

When did Ascentage Pharma Group International go public?

Ascentage Pharma Group International's initial public offering (IPO) was on January 24, 2025

Is Ascentage Pharma Group International in the S&P 500?

No, Ascentage Pharma Group International is not included in the S&P 500 index

Is Ascentage Pharma Group International in the NASDAQ 100?

No, Ascentage Pharma Group International is not included in the NASDAQ 100 index

Is Ascentage Pharma Group International in the Dow Jones?

No, Ascentage Pharma Group International is not included in the Dow Jones index

When was Ascentage Pharma Group International's last earnings report?

Ascentage Pharma Group International's most recent earnings report was on Mar 27, 2025

When does Ascentage Pharma Group International report earnings?

The next expected earnings date for Ascentage Pharma Group International is Aug 22, 2025
On this page